HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$6.87
Day range
$6.75 - $7.06
Year range
$1.06 - $11.88
Market cap
474.03M USD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.26M | 14.26% |
Operating expense | 10.30M | -1.89% |
Net income | -34.75M | 6.54% |
Net profit margin | -1.07K | 18.20% |
Earnings per share | -0.68 | 10.53% |
EBITDA | -37.00M | 2.05% |
Effective tax rate | -0.80% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 253.68M | -8.14% |
Total assets | 376.45M | -12.62% |
Total liabilities | 130.34M | -7.96% |
Total equity | 246.11M | — |
Shares outstanding | 68.60M | — |
Price to book | 1.69 | — |
Return on assets | -26.38% | — |
Return on capital | -30.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -34.75M | 6.54% |
Cash from operations | -24.01M | 17.57% |
Cash from investing | 31.94M | 244.09% |
Cash from financing | 57.67M | 122,606.38% |
Net change in cash | 65.61M | 431.40% |
Free cash flow | -14.79M | 20.76% |
About
Founded
2015
Headquarters
Website
Employees
145